NU2058 50 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
Search Results
NU2058 25 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 10 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 100 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
Metadoxine 100 mg | Purity Not Available
TargetMol
Metadoxine
Metadoxine 50 mg | Purity Not Available
TargetMol
Metadoxine
Tulobuterol hydrochloride 100 mg | Purity Not Available
TargetMol
Tulobuterol hydrochloride is a long-acting beta2-adrenergic receptor agonist.
More Information Supplier PageTulobuterol hydrochloride
Tulobuterol hydrochloride 50 mg | Purity Not Available
TargetMol
Tulobuterol hydrochloride is a long-acting beta2-adrenergic receptor agonist.
More Information Supplier PageTulobuterol hydrochloride
5-methoxyflavone 50 mg | 99.97%
TargetMol
5-methoxyflavone (5-methoxy-2-phenylchromen-4-one) is a naturally occurring, low molecular weight flavonoids compound that associated with a wide wariety of biological activities.
More Information Supplier Page5-methoxyflavone
Naloxegol oxalate 100 mg | 99.82%
TargetMol
Naloxegol oxalate is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation.
More Information Supplier PageNaloxegol oxalate
